NPI: 1871995969 · BATON ROUGE, LA 70802 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/19/2014
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 09/19/2014 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,047 | $0.00 |
| 2019 | 1,840 | $0.00 |
| 2020 | 520 | $0.00 |
| 2021 | 36 | $5K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 36 | 13 | $5K |
| A4657 | Syringe, with or without needle, each | 391 | 283 | $0.00 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 3,477 | 228 | $0.00 |
| 83550 | 62 | 49 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 49 | 25 | $0.00 |
| 82728 | 81 | 64 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 39 | 12 | $0.00 |
| 85048 | 83 | 63 | $0.00 | |
| 83540 | 62 | 49 | $0.00 | |
| 85041 | 83 | 63 | $0.00 | |
| 83970 | 80 | 65 | $0.00 |